XETR
SY1
Market cap13bUSD
Jun 18, Last price
85.54EUR
1D
2.13%
1Q
23.19%
Jan 2017
47.69%
IPO
357.43%
Name
Symrise AG
Chart & Performance
P/E
25.00
P/S
2.39
EPS
3.42
Div Yield, %
—
Shrs. gr., 5y
0.10%
Rev. gr., 5y
7.96%
Revenues
5.00b
+5.67%
Net income
478m
+40.45%
CFO
895m
+24.38%
Dividend
May 21, 20250 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Symrise AG, founded in 1874 and based in Holzminden, Germany, specializes in offering a wide array of products including scents, flavorings, active components for cosmetics, various raw materials, and functional ingredients. The company's business activities are structured into two primary divisions: Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional compounds and taste solutions, predominantly for the food and beverage sectors. This encompasses savory flavor profiles; natural and sustainably sourced ingredients for manufacturers of food, beverages, infant formula, and dietary supplements; complete product solutions and support for pet food producers; environmentally conscious ingredients and services for aquaculture, facilitating the development of solutions for fish and shrimp farms; and probiotic cultures intended for nutritional supplements and health-focused food items. Conversely, the Scent & Care division is dedicated to the formulation, manufacturing, and distribution of fragrance elements, aroma chemicals, cosmetic raw materials, and mint flavors, alongside specialized application techniques for these materials. This segment's diverse offerings are utilized by companies producing perfumes, personal care items, cosmetics, cleaning products, laundry detergents, air fresheners, and oral hygiene solutions. Globally, Symrise AG conducts its operations across Europe, Africa, the Middle East, North America, the Asia Pacific region, and Latin America.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||